Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AxonPrime Infrastructure Acquisition CorpAPMIU · Entity 136141 | 10% owner | August 17, 2021 | August 19, 2021 |
| Heliogen, Inc.HLGN · Entity 78373 | 10% owner | June 12, 2023 | June 14, 2023 |
| Momentus Inc.MNTS · Entity 6834 | 10% owner | September 22, 2023 | September 26, 2023 |
| Vaxxinity, Inc.VAXX · Entity 91688 | 10% owner | September 06, 2023 | September 08, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AxonPrime Infrastructure Acquisition Corp
Report date August 17, 2021 · Filed August 19, 2021
Jointly reported with AxonPrime Infrastructure Sponsor LLC, Prime Infrastructure Sponsor LLC, Axon Infrastructure Sponsor LLC, AxonPrime Infrastructure Sponsor JV LLC, Singh Dinakar
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,500,000 |
Reported balance
After 2021-08-17 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-08-17 · Purchase · Acquired 1,500,000 · Balance 1,500,000 F1: Represents 1,500,000 shares of Class A Common Stock acquired in connection with the purchase of 1,500,000 units of the issuer (each consisting of one share of Class A Common Stock and one-third of one redeemable warrant) indirectly through Axon Partners, LP, which is the record holder of such shares. Axon Partners, LP is controlled by Dinakar Singh. Axon Partners, LP, together with Axon Capital LP, its investment manager, which is also controlled by Mr. Singh, has separately filed a Form 3 reporting such acquisition. The securities reported in this Form 4 do not include 500,000 shares of Class A common stock issuable upon the exercise of the warrants included as part of such units. Mr. Singh disclaims any beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 3,587,500 |
Reported balance
After 2021-08-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-08-17 · Sale · Disposed 650,000 · Balance 3,587,500 F2: As described in the issuer's final prospectus filed under Rule 424(b)(4) (File No. 333-257777) (the "Prospectus") under the heading "Description of Securities--Founder Shares," the shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the initial business combination of the issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date. F3: The shares of Class B Common Stock were sold by AxonPrime Infrastructure Sponsor LLC (the "Sponsor") to certain institutional investors and qualified institutional buyers, as described in the Prospectus under the heading "Summary - The Offering - Expressions of Interest." F4: Includes up to 562,500 shares of Class B Common Stock which are subject to forfeiture depending on the extent to which the underwriters' over-allotment option is exercised in connection with the issuer's initial public offering, as described in the Prospectus. F5: The Sponsor is the record holder of the securities. The Sponsor is a direct subsidiary of AxonPrime Infrastructure Sponsor JV LLC. 50% of the equity interests in AxonPrime Infrastructure Sponsor JV LLC are directly owned by Prime Infrastructure Sponsor LLC and 50% of such interests are directly owned by Axon Infrastructure Sponsor LLC. Prime Infrastructure Sponsor LLC is controlled by Dakin Sloss and Axon Infrastructure Sponsor LLC is controlled by Mr. Singh. As such, each of Messrs. Singh and Sloss may be deemed to share beneficial ownership of the securities held directly by the Sponsor. Each of Messrs. Singh and Sloss disclaim any beneficial ownership of such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 1,500,000 shares of Class A Common Stock acquired in connection with the purchase of 1,500,000 units of the issuer (each consisting of one share of Class A Common Stock and one-third of one redeemable warrant) indirectly through Axon Partners, LP, which is the record holder of such shares. Axon Partners, LP is controlled by Dinakar Singh. Axon Partners, LP, together with Axon Capital LP, its investment manager, which is also controlled by Mr. Singh, has separately filed a Form 3 reporting such acquisition. The securities reported in this Form 4 do not include 500,000 shares of Class A common stock issuable upon the exercise of the warrants included as part of such units. Mr. Singh disclaims any beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
F2: As described in the issuer's final prospectus filed under Rule 424(b)(4) (File No. 333-257777) (the "Prospectus") under the heading "Description of Securities--Founder Shares," the shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the initial business combination of the issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date.
F3: The shares of Class B Common Stock were sold by AxonPrime Infrastructure Sponsor LLC (the "Sponsor") to certain institutional investors and qualified institutional buyers, as described in the Prospectus under the heading "Summary - The Offering - Expressions of Interest."
F4: Includes up to 562,500 shares of Class B Common Stock which are subject to forfeiture depending on the extent to which the underwriters' over-allotment option is exercised in connection with the issuer's initial public offering, as described in the Prospectus.
F5: The Sponsor is the record holder of the securities. The Sponsor is a direct subsidiary of AxonPrime Infrastructure Sponsor JV LLC. 50% of the equity interests in AxonPrime Infrastructure Sponsor JV LLC are directly owned by Prime Infrastructure Sponsor LLC and 50% of such interests are directly owned by Axon Infrastructure Sponsor LLC. Prime Infrastructure Sponsor LLC is controlled by Dakin Sloss and Axon Infrastructure Sponsor LLC is controlled by Mr. Singh. As such, each of Messrs. Singh and Sloss may be deemed to share beneficial ownership of the securities held directly by the Sponsor. Each of Messrs. Singh and Sloss disclaim any beneficial ownership of such securities.
Heliogen, Inc.
Report date June 12, 2023 · Filed June 14, 2023
Jointly reported with Prime Movers Lab Fund I LP, Heliogen PML SPV 1 LP, Prime Movers Lab GP I LLC, Prime Movers Lab GP II LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by Prime Movers Lab Fund I LP | 10,477,320 |
Last balance in matching sequence
After 2023-06-13 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-06-12 · Sale · Disposed 275,000 · Balance 13,402,320 F4: The price of $0.2035 per share represents a weighted average of purchase prices ranging from $0.1985 to $0.2231 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 2 · 2023-06-13 · Sale · Disposed 2,925,000 · Balance 10,477,320 F5: The price of $0.1997 per share represents a weighted average of purchase prices ranging from $0.1910 to $0.2101 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Heliogen PML SPV 1 LP | 6,668,457 |
Reported balance
Holding disclosure · report date 2023-06-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,668,457 F2: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML. F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML.
F2: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML.
F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F4: The price of $0.2035 per share represents a weighted average of purchase prices ranging from $0.1985 to $0.2231 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F5: The price of $0.1997 per share represents a weighted average of purchase prices ranging from $0.1910 to $0.2101 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Momentus Inc.
Report date September 22, 2023 · Filed September 26, 2023
Jointly reported with Prime Movers Lab Fund I LP, Prime Movers Growth Fund I LP, Momentus PML SPV 1 LP, MOMENTUS PML SPV 2 LP, Momentus PML SPV 3 LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 77,837 |
Last balance in matching sequence
After 2023-09-25 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-09-22 · Sale · Disposed 13,574 · Balance 109,098 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 6 · 2023-09-25 · Sale · Disposed 31,261 · Balance 77,837 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 1 LP | 30,853 |
Last balance in matching sequence
After 2023-09-25 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2023-09-22 · Sale · Disposed 5,381 · Balance 43,245 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 7 · 2023-09-25 · Sale · Disposed 12,392 · Balance 30,853 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 2 LP | 8,520 |
Reported balance
After 2023-09-22 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2023-09-22 · Sale · Disposed 1,060 · Balance 8,520 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 3 LP | 21,133 |
Reported balance
After 2023-09-22 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2023-09-22 · Sale · Disposed 2,630 · Balance 21,133 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund I LP | 8,418 |
Reported balance
After 2023-09-22 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2023-09-22 · Sale · Disposed 1,048 · Balance 8,418 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 2 LP | 4,734 |
Last balance in matching sequence
After 2023-09-26 transaction · row 13
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 8 · 2023-09-25 · Sale · Disposed 2,442 · Balance 6,078 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 13 · 2023-09-26 · Sale · Disposed 1,344 · Balance 4,734 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 3 LP | 11,745 |
Last balance in matching sequence
After 2023-09-26 transaction · row 14
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 9 · 2023-09-25 · Sale · Disposed 6,056 · Balance 15,077 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 14 · 2023-09-26 · Sale · Disposed 3,332 · Balance 11,745 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund I LP | 4,679 |
Last balance in matching sequence
After 2023-09-26 transaction · row 15
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 10 · 2023-09-25 · Sale · Disposed 2,412 · Balance 6,006 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 15 · 2023-09-26 · Sale · Disposed 1,327 · Balance 4,679 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 60,635 |
Reported balance
After 2023-09-26 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2023-09-26 · Sale · Disposed 17,202 · Balance 60,635 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 1 LP | 24,034 |
Reported balance
After 2023-09-26 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2023-09-26 · Sale · Disposed 6,819 · Balance 24,034 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML.
F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1.
F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth.
F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Vaxxinity, Inc.
Report date September 06, 2023 · Filed September 08, 2023
Jointly reported with Prime Movers Lab Fund I LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 1 LP | 2,058,990 |
Last balance in matching sequence
After 2023-09-07 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-09-06 · Sale · Disposed 1,251 · Balance 2,063,776 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 6 · 2023-09-07 · Sale · Disposed 4,786 · Balance 2,058,990 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 8,738,752 |
Last balance in matching sequence
After 2023-09-07 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2023-09-06 · Sale · Disposed 5,308 · Balance 8,759,064 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by PML. PML GP I is the general partner of PML. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 7 · 2023-09-07 · Sale · Disposed 20,312 · Balance 8,738,752 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by PML. PML GP I is the general partner of PML. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 2 LP | 831,658 |
Last balance in matching sequence
After 2023-09-08 transaction · row 13
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 3 · 2023-09-06 · Sale · Disposed 507 · Balance 835,992 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 8 · 2023-09-07 · Sale · Disposed 1,939 · Balance 834,053 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 13 · 2023-09-08 · Sale · Disposed 2,395 · Balance 831,658 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 3 LP | 1,472,208 |
Reported balance
After 2023-09-06 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2023-09-06 · Sale · Disposed 892 · Balance 1,472,208 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund 1 LP | 3,612,849 |
Reported balance
After 2023-09-06 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2023-09-06 · Sale · Disposed 2,189 · Balance 3,612,849 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 3 LP | 1,464,578 |
Last balance in matching sequence
After 2023-09-08 transaction · row 14
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 9 · 2023-09-07 · Sale · Disposed 3,413 · Balance 1,468,795 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 14 · 2023-09-08 · Sale · Disposed 4,217 · Balance 1,464,578 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund 1 LP | 3,594,122 |
Last balance in matching sequence
After 2023-09-08 transaction · row 15
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 10 · 2023-09-07 · Sale · Disposed 8,378 · Balance 3,604,471 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 15 · 2023-09-08 · Sale · Disposed 10,349 · Balance 3,594,122 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 1 LP | 2,053,079 |
Reported balance
After 2023-09-08 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2023-09-08 · Sale · Disposed 5,911 · Balance 2,053,079 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | Direct | 8,713,663 |
Reported balance
After 2023-09-08 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2023-09-08 · Sale · Disposed 25,089 · Balance 8,713,663 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by PML. PML GP I is the general partner of PML. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
F3: Held by PML. PML GP I is the general partner of PML.
F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 07, 2023 Filed Sep 11, 2023 18:05 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 906 | $6.51 | $5,895.80 |
DisclosureSEC source: 0001062993-23-017915 · form4.xml · nonDerivative · entry 5 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Prime Movers Growth Fund I LP Disclosed balance after: 18,080 F7 · price: The price of $6.5075 per share represents a weighted average of purchase prices ranging from $6.010 to $7.350 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.nature: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6 · ownership.nature: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 18:05 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 2,276 | $6.51 | $14,811.07 |
DisclosureSEC source: 0001062993-23-017915 · form4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Momentus PML SPV 3 LP Disclosed balance after: 45,387 F7 · price: The price of $6.5075 per share represents a weighted average of purchase prices ranging from $6.010 to $7.350 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4 · ownership.nature: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6 · ownership.nature: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 18:05 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 917 | $6.51 | $5,967.38 |
DisclosureSEC source: 0001062993-23-017915 · form4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Momentus PML SPV 2 LP Disclosed balance after: 18,300 F7 · price: The price of $6.5075 per share represents a weighted average of purchase prices ranging from $6.010 to $7.350 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6 · ownership.nature: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 18:05 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 4,656 | $6.51 | $30,298.92 |
DisclosureSEC source: 0001062993-23-017915 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Momentus PML SPV 1 LP Disclosed balance after: 92,871 F7 · price: The price of $6.5075 per share represents a weighted average of purchase prices ranging from $6.010 to $7.350 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 18:05 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 11,748 | $6.51 | $76,450.11 |
DisclosureSEC source: 0001062993-23-017915 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,295 F7 · price: The price of $6.5075 per share represents a weighted average of purchase prices ranging from $6.010 to $7.350 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.direct: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 18:05 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 2,189 | $1.88 | $4,120.35 |
DisclosureSEC source: 0001062993-23-017880 · form4.xml · nonDerivative · entry 5 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Prime Movers Growth Fund 1 LP Disclosed balance after: 3,612,849 F1 · price: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6 · ownership.nature: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 18:05 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 892 | $1.88 | $1,679.01 |
DisclosureSEC source: 0001062993-23-017880 · form4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by COVAXX PML SPV 3 LP Disclosed balance after: 1,472,208 F1 · price: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.nature: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 18:05 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 507 | $1.88 | $954.33 |
DisclosureSEC source: 0001062993-23-017880 · form4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by COVAXX PML SPV 2 LP Disclosed balance after: 835,992 F1 · price: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4 · ownership.nature: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 18:05 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 5,308 | $1.88 | $9,991.25 |
DisclosureSEC source: 0001062993-23-017880 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,759,064 F1 · price: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F7 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 18:05 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 1,251 | $1.88 | $2,354.76 |
DisclosureSEC source: 0001062993-23-017880 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,063,776 F1 · price: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 16:15 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 2,925,000 | $0.20 | $584,122.50 |
DisclosureSEC source: 0001062993-23-013519 · form4.xml · nonDerivative · entry 2 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Prime Movers Lab Fund I LP Disclosed balance after: 10,477,320 F5 · price: The price of $0.1997 per share represents a weighted average of purchase prices ranging from $0.1910 to $0.2101 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 16:15 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 275,000 | $0.20 | $55,962.50 |
DisclosureSEC source: 0001062993-23-013519 · form4.xml · nonDerivative · entry 1 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Prime Movers Lab Fund I LP Disclosed balance after: 13,402,320 F4 · price: The price of $0.2035 per share represents a weighted average of purchase prices ranging from $0.1985 to $0.2231 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 16:14 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 722,301 | $0.27 | $192,059.84 |
DisclosureSEC source: 0001062993-23-013266 · form4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Momentus PML SPV 1 LP Disclosed balance after: 4,876,327 F8 · price: The price of $0.2659 per share represents a weighted average of purchase prices ranging from $0.2610 to $0.3100 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 16:14 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 1,822,239 | $0.27 | $484,533.35 |
DisclosureSEC source: 0001062993-23-013266 · form4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,302,114 F8 · price: The price of $0.2659 per share represents a weighted average of purchase prices ranging from $0.2610 to $0.3100 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.direct: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 18:35 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 6,917 | $0.22 | $1,525.89 |
DisclosureSEC source: 0001062993-23-013381 · form4.xml · nonDerivative · entry 2 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Prime Movers Lab Fund II LP · CIK 0001807277 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Prime Movers Lab Fund II LP Disclosed balance after: 0 F5 · price: The price of $0.2206 per share represents a weighted average of purchase prices ranging from $0.2134 to $0.2330 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Prime Movers Lab Fund II LP ("PML Fund II"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML Fund II. F4 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML, PML Fund II and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 18:35 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 3,593,083 | $0.22 | $792,634.11 |
DisclosureSEC source: 0001062993-23-013381 · form4.xml · nonDerivative · entry 1 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Prime Movers Lab Fund II LP · CIK 0001807277 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Prime Movers Lab Fund I LP Disclosed balance after: 13,677,320 F5 · price: The price of $0.2206 per share represents a weighted average of purchase prices ranging from $0.2134 to $0.2330 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F4 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML, PML Fund II and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:14 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 413,152 | $0.31 | $126,796.35 |
DisclosureSEC source: 0001062993-23-013266 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Momentus PML SPV 1 LP Disclosed balance after: 5,598,628 F7 · price: The price of $0.3069 per share represents a weighted average of purchase prices ranging from $0.30000 to $0.35035 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:14 UTC | Momentus Inc. MNTS · Entity 6834 | SaleClass A common stock | 1,042,308 | $0.31 | $319,884.33 |
DisclosureSEC source: 0001062993-23-013266 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Growth Fund I LP · CIK 0001838981 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,124,353 F7 · price: The price of $0.3069 per share represents a weighted average of purchase prices ranging from $0.30000 to $0.35035 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.direct: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:58 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A common stock | 405,217 | $3.35 | $1,358,044.25 |
DisclosureSEC source: 0001062993-23-001392 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,764,372 F1 · price: The price of $3.3514 per share represents a weighted average of purchase prices ranging from $3.19 to $3.62 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F7 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 17:58 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A common stock | 95,475 | $3.35 | $319,974.92 |
DisclosureSEC source: 0001062993-23-001392 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,065,027 F1 · price: The price of $3.3514 per share represents a weighted average of purchase prices ranging from $3.19 to $3.62 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:31 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 11,121 | $2.57 | $28,560.95 |
DisclosureSEC source: 0001062993-22-023345 · form4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,169,589 F4 · price: The price of $2.5682 per share represents a weighted average of purchase prices ranging from $2.86 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F8 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:31 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 2,620 | $2.57 | $6,728.68 |
DisclosureSEC source: 0001062993-22-023345 · form4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,160,502 F4 · price: The price of $2.5682 per share represents a weighted average of purchase prices ranging from $2.86 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F8 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:31 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 270,964 | $2.97 | $805,223.72 |
DisclosureSEC source: 0001062993-22-023345 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,180,710 F1 · price: The price of $2.9717 per share represents a weighted average of purchase prices ranging from $3.38 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F8 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:31 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 63,843 | $2.97 | $189,722.24 |
DisclosureSEC source: 0001062993-22-023345 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,163,122 F1 · price: The price of $2.9717 per share represents a weighted average of purchase prices ranging from $3.38 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F8 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 16:55 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 25,243 | $2.40 | $60,656.40 |
DisclosureSEC source: 0001062993-22-019372 · form4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,451,674 F7 · price: The price of $2.4029 per share represents a weighted average of purchase prices ranging from $2.40 to $2.42 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 16:55 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 3,934 | $2.40 | $9,453.01 |
DisclosureSEC source: 0001062993-22-019372 · form4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 3 LP Disclosed balance after: 1,473,100 F7 · price: The price of $2.4029 per share represents a weighted average of purchase prices ranging from $2.40 to $2.42 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 16:55 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 2,234 | $2.40 | $5,368.08 |
DisclosureSEC source: 0001062993-22-019372 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 2 LP Disclosed balance after: 836,499 F7 · price: The price of $2.4029 per share represents a weighted average of purchase prices ranging from $2.40 to $2.42 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 16:55 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 5,947 | $2.40 | $14,290.05 |
DisclosureSEC source: 0001062993-22-019372 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,226,965 F7 · price: The price of $2.4029 per share represents a weighted average of purchase prices ranging from $2.40 to $2.42 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A common stock | 22,757 | $2.33 | $53,046.57 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 12 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,476,917 F9 · price: The price of $2.3310 per share represents a weighted average of purchase prices ranging from $2.31 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A common stock | 3,547 | $2.33 | $8,268.06 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 11 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 3 LP Disclosed balance after: 1,477,034 F9 · price: The price of $2.3310 per share represents a weighted average of purchase prices ranging from $2.31 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A common stock | 2,014 | $2.33 | $4,694.63 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 10 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 2 LP Disclosed balance after: 838,733 F9 · price: The price of $2.3310 per share represents a weighted average of purchase prices ranging from $2.31 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A common stock | 5,362 | $2.33 | $12,498.82 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 9 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,232,912 F9 · price: The price of $2.3310 per share represents a weighted average of purchase prices ranging from $2.31 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 83,786 | $2.39 | $199,930.15 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 8 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,499,674 F8 · price: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.38 to $2.45 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 13,058 | $2.39 | $31,159.00 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 7 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 3 LP Disclosed balance after: 1,480,581 F8 · price: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.38 to $2.45 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 7,415 | $2.39 | $17,693.67 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 6 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 2 LP Disclosed balance after: 840,747 F8 · price: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.38 to $2.45 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 19,741 | $2.39 | $47,105.97 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 5 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,238,274 F8 · price: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.38 to $2.45 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 33,785 | $2.45 | $82,658.38 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,583,460 F7 · price: The price of $2.4466 per share represents a weighted average of purchase prices ranging from $2.35 to $2.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 5,265 | $2.45 | $12,881.35 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 3 LP Disclosed balance after: 1,493,639 F7 · price: The price of $2.4466 per share represents a weighted average of purchase prices ranging from $2.35 to $2.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3 · ownership.nature: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 2,990 | $2.45 | $7,315.33 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 2 LP Disclosed balance after: 848,162 F7 · price: The price of $2.4466 per share represents a weighted average of purchase prices ranging from $2.35 to $2.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 18:02 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 7,960 | $2.45 | $19,474.94 |
DisclosureSEC source: 0001062993-22-018766 · form4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,258,015 F7 · price: The price of $2.4466 per share represents a weighted average of purchase prices ranging from $2.35 to $2.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F6 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 30, 2022 Filed Jun 30, 2022 19:20 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 56,606 | $1.99 | $112,747.83 |
DisclosureSEC source: 0001062993-22-015696 · form4.xml · nonDerivative · entry 6 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,001,611 F6 · price: The price of $1.9918 per share represents a weighted average of purchase prices ranging from $1.86 to $2.21 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 30, 2022 Filed Jun 30, 2022 19:20 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 169,180 | $1.99 | $336,972.72 |
DisclosureSEC source: 0001062993-22-015696 · form4.xml · nonDerivative · entry 5 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,937,249 F6 · price: The price of $1.9918 per share represents a weighted average of purchase prices ranging from $1.86 to $2.21 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 30, 2022 Filed Jul 12, 2022 11:36 UTC Amendment | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 225,786 | $1.99 | $449,720.55 |
DisclosureSEC source: 0001062993-22-016241 · form4a.xml · nonDerivative · entry 3 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,270,403 F1 · kind: This amendment is filed solely to correct the source of the shares reported as sold and to correct a technical error that caused the omission of Prime Movers Lab GP I LLC ("PML GP") and Prime Movers Lab GP II LLC ("PML GP II") as reporting persons. F7 · price: The price of $1.9918 per share represents a weighted average of purchase prices ranging from $1.86 to $2.21 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). PML GP is the general partner of PML. F4 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 29, 2022 Filed Jun 30, 2022 19:20 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 352,350 | $2.02 | $713,262.11 |
DisclosureSEC source: 0001062993-22-015696 · form4.xml · nonDerivative · entry 4 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,058,217 F5 · price: The price of $2.0243 per share represents a weighted average of purchase prices ranging from $1.96 to $2.63 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 29, 2022 Filed Jun 30, 2022 19:20 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 1,053,084 | $2.02 | $2,131,757.94 |
DisclosureSEC source: 0001062993-22-015696 · form4.xml · nonDerivative · entry 3 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,106,429 F5 · price: The price of $2.0243 per share represents a weighted average of purchase prices ranging from $1.96 to $2.63 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 29, 2022 Filed Jul 12, 2022 11:36 UTC Amendment | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 1,405,434 | $2.02 | $2,845,020.05 |
DisclosureSEC source: 0001062993-22-016241 · form4a.xml · nonDerivative · entry 2 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,496,189 F1 · kind: This amendment is filed solely to correct the source of the shares reported as sold and to correct a technical error that caused the omission of Prime Movers Lab GP I LLC ("PML GP") and Prime Movers Lab GP II LLC ("PML GP II") as reporting persons. F6 · price: The price of $2.0243 per share represents a weighted average of purchase prices ranging from $1.96 to $2.63 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). PML GP is the general partner of PML. F4 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 19:20 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 257,890 | $2.82 | $726,269.82 |
DisclosureSEC source: 0001062993-22-015696 · form4.xml · nonDerivative · entry 2 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,410,567 F4 · price: The price of $2.8162 per share represents a weighted average of purchase prices ranging from $2.485 to $3.13 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 19:20 UTC | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 770,764 | $2.82 | $2,170,625.58 |
DisclosureSEC source: 0001062993-22-015696 · form4.xml · nonDerivative · entry 1 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 19,159,513 F4 · price: The price of $2.8162 per share represents a weighted average of purchase prices ranging from $2.485 to $3.13 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 28, 2022 Filed Jul 12, 2022 11:36 UTC Amendment | Heliogen, Inc. HLGN · Entity 78373 | SaleCommon Stock | 1,028,654 | $2.82 | $2,896,895.39 |
DisclosureSEC source: 0001062993-22-016241 · form4a.xml · nonDerivative · entry 1 Sloss Dakin · CIK 0001875411 · 10% owner Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Heliogen PML SPV 1 LP · CIK 0001839170 · 10% owner Prime Movers Lab GP I LLC · CIK 0001937419 · 10% owner Prime Movers Lab GP II LLC · CIK 0001937460 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,901,623 F1 · kind: This amendment is filed solely to correct the source of the shares reported as sold and to correct a technical error that caused the omission of Prime Movers Lab GP I LLC ("PML GP") and Prime Movers Lab GP II LLC ("PML GP II") as reporting persons. F5 · price: The price of $2.8162 per share represents a weighted average of purchase prices ranging from $2.485 to $3.13 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Held by Prime Movers Lab Fund I LP ("PML"). PML GP is the general partner of PML. F4 · ownership.nature: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 19:08 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | SaleClass A Common Stock | 92,569 | $2.43 | $224,563.14 |
DisclosureSEC source: 0001062993-22-014846 · form4.xml · nonDerivative · entry 8 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,617,245 F8 · price: The price of $2.4259 per share represents a weighted average of purchase prices ranging from $2.27 to $2.77 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F6 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.